about
A Monovalent Chimpanzee Adenovirus Ebola Vaccine Boosted with MVAHepatitis E: the current state of play.Quantitation of hepatitis C virus using an in-house real-time reverse transcriptase polymerase chain reaction in plasma samples.Acute hepatitis B virus infection with delayed appearance of hepatitis B core antibody in an immunocompromised patient: a case report.Global control of hepatitis B virus: does treatment-induced antigenic change affect immunization?Hepatitis E and blood donation safety in selected European countries: a shift to screening?Ebola exposure, illness experience, and Ebola antibody prevalence in international responders to the West African Ebola epidemic 2014-2016: A cross-sectional study.Evaluation of an ethidium monoazide-enhanced 16S rDNA real-time polymerase chain reaction assay for bacterial screening of platelet concentrates and comparison with automated culturePrevalence of Hepatitis E Virus Infection in Pigs at the Time of Slaughter, United Kingdom, 2013.Detection of Vaccine-Induced Antibodies to Ebola Virus in Oral FluidVariability and pathogenicity of hepatitis E virus genotype 3 variants.Transmission of hepatitis B virus (genotype E) in a haemodialysis unit.A re-assessment of the epidemiology and patient characteristics of hepatitis D virus infection in inner city London.Pork products associated with human infection caused by an emerging phylotype of hepatitis E virus in England and Wales.Racial differences in seroprevalence of HAV and HEV in blood donors in the Western Cape, South Africa: a clue to the predominant HEV genotype?Hepatitis E risks: pigs or blood-that is the question.Asymptomatic infection and unrecognised Ebola virus disease in Ebola-affected households in Sierra Leone: a cross-sectional study using a new non-invasive assay for antibodies to Ebola virus.Summary of the British Transplantation Society UK Guidelines for Hepatitis E and Solid Organ Transplantation.Use of genome sequencing to identify hepatitis C virus transmission in a renal healthcare setting.Virology, serology, and demography of hepatitis E viremic blood donors in South East England.Molecular epidemiology of newly acquired hepatitis C infections in England 2008-2011: genotype, phylogeny and mutation analysis.No evidence of transfusion transmission of Adenovirus and Epstein-Barr virus infections in paediatric recipients post-bone marrow transplant.Using data linkage to improve surveillance methods for acute hepatitis E infections in England and Wales 2010-2016.Hepatitis E virus in blood components: a prevalence and transmission study in southeast England.Transmission of hepatitis C from a midwife to a patient through non-exposure prone procedures.Acute hepatitis B in blood donors over a 5-year period in England and North Wales: who is getting infected?Indigenous hepatitis E in England and wales from 2003 to 2012: evidence of an emerging novel phylotype of viruses.Hepatitis E virus in England and Wales: indigenous infection is associated with the consumption of processed pork products.The diversity and management of chronic hepatitis B virus infections in the United Kingdom: a wake-up call.Therapy-induced clearance of HCV core antigen from plasma predicts an end of treatment viral response.Hepatitis C virus window-phase infections: closing the window on hepatitis C virus.A low rate of hepatitis B virus vaccine breakthrough infections in Mongolia.Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?Persistent carriage of hepatitis E virus in patients with HIV infection.Investigating the impact of hepatitis B virus surface gene polymorphism on antigenicity using ex vivo phenotyping.Detection of hepatitis E virus RNA in plasma mini-pools from blood donors in England.Dynamics of lamivudine-resistant hepatitis B virus during adefovir monotherapy versus lamivudine plus adefovir combination therapy.Predictors and kinetics of occult hepatitis B virus infection in HIV-infected persons.Stage of disease in hepatitis B virus infection in Zambian adults is associated with large cell change but not well defined using classic biomarkers.Confirmation of specificity of reactivity in a solid phase ELISA for the detection of hepatitis E viral antigen improves utility of the assay.
P50
Q24289279-B168E454-9B81-408A-B4CA-908317718505Q30234939-0F0DF8CB-8AC0-4114-932C-A63750AAC6AEQ33335534-E047B7A7-346F-47DC-ACF8-53F1659A5F24Q33568712-EC93E468-2B1F-437C-BD6A-FFC7448F6AE1Q33574740-7E4C0F60-04F7-4282-A7E6-6690DDB5A92FQ33601663-8E98785C-EE49-4499-B431-D6AA20A81EDEQ33693686-53F2EA65-676A-41E3-924D-4847ECF7220DQ34805484-7A1290DC-0593-4926-9A0B-5DC5D6076230Q35897034-7C64A20D-6D85-4F74-A33D-28D04A2C42CDQ36700388-C2D2BAE7-2A4D-4681-8675-1700F9C1F985Q36725544-7BA8E0FF-F744-427C-915B-F383019F9652Q36934544-5119D6C6-2C95-4AF3-B092-8DA10237D94BQ38427445-B32DABD6-28E1-4A3C-8709-25B48C592F17Q38653132-F9BD583A-9C79-4AE3-ADF2-9BBB28A3870CQ38867659-753933F1-1AFD-4F4A-85BA-869958F7D090Q38962790-89E70543-F3DE-4869-87F4-80FC138C037FQ39025434-5859CF67-3DF8-4977-9C18-B0D729EA6D60Q40088071-59E1CD7C-70AE-48FD-B1F8-76A3D5DA9DECQ40333443-36BB5F69-2320-4E36-AFD6-A370F4E5C987Q40806990-CF4FE38B-B3CB-4485-A9CD-B7444E844A0FQ41331002-B651D7E8-28C1-4671-9779-7869796508F1Q41366529-9A30DD25-CC57-4920-B613-9543FCFF70E5Q41930509-3A8ED82A-5B94-4F47-9339-61EDAF416176Q42202761-50685082-63CA-43DC-9196-DB3FAD5122AFQ42242691-12197AE8-1C54-4309-AA97-719A2489A4C9Q42253141-6BCD88A4-A3DC-4BF0-995F-96CDB7D85236Q42253296-75E201F3-2CFE-4ED3-87FB-ED5302FC20F4Q42268101-B45C294B-E768-4874-8242-D1E06372D14BQ42517674-7A499A16-D16E-4F03-8C56-3872730A15C0Q42987172-2DD18972-FDAC-4F9E-8221-C89F627F5D90Q43047661-EA4CBD2B-AB16-4907-8DBE-679D064BE30BQ44035262-0307D265-9E75-457F-8A92-EC98FAF81857Q44764764-2A378910-87A7-4357-8A53-6722623A06A6Q45019291-BCCB5679-CD37-4EE9-88AC-8C46367971FEQ45355772-87748C3D-C8DF-4088-9AA4-24E87F961437Q45362903-D7D86F9C-556F-4FFB-9A1A-89833CDECF90Q45395245-A9531644-C3D9-4083-8368-744552229877Q45401074-0F72BC38-87F9-4410-A14C-12557AC2B385Q47548262-7092106E-272A-46C0-898F-098036D9E895Q47575017-45340F6A-370E-41D1-BED9-D86FD5DC5247
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Richard S Tedder
@en
Richard S Tedder
@nl
type
label
Richard S Tedder
@en
Richard S Tedder
@nl
prefLabel
Richard S Tedder
@en
Richard S Tedder
@nl
P31
P496
0000-0002-9672-5721